Ponatinib and Blinatumomab for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Single-Arm, Phase 2 Trial
Year: 2022
Type: preprint
Study design: Clinical Trial
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.4094834
Authors: Elias Jabbour, Nicholas Short, Nitin Jain, Xuelin Huang, Guillermo Montalban-Bravo, Pinaki Banerjee, Katy Rezvani, Tapan M. Kadia, Naval Daver, Kelly Chien, Yesid Alvarado, Guillermo Garcia-Manero, Ghayas Issa, Fadi G. Haddad, Monica Kwari, Jennifer Thankachan, Ricardo Delumpa, Walid Macaron, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4285215475